|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
|
Synonyms | JNK Inhibitor XVI | Storage (From the date of receipt) |
3 years -20°C powder 1 years -80°C in solvent |
|||||||
| 化学式 | C29H29N7O2 |
||||||||||
| 分子量 | 507.59 | CAS No. | 1410880-22-6 | ||||||||
| Solubility (25°C)* | 体外 | DMSO (warmed with 50ºC water bath) | 100 mg/mL (197.0 mM) | ||||||||
| Water | Insoluble | ||||||||||
| Ethanol | Insoluble | ||||||||||
| 体内 (毎回新しく調製した物を用意してください) |
|
||||||||||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||||||||||
| 製品説明 | JNK-IN-8 (JNK Inhibitor XVI) is the first irreversible JNK inhibitor for JNK1, JNK2 and JNK3 with IC50 of 4.7 nM, 18.7 nM and 1 nM, >10-fold selectivity against MNK2, Fms and no inhibition to c-Kit, Met, PDGFRβin A375 cell line. |
|---|---|
| in vitro | JNK-IN-8 inhibits c-Jun phosphorylation in HeLa and A375 cells with EC50 of 486 nM and 338 nM, respectively. This compound shows a dramatic improvement in selectivity and eliminated binding to IRAK1, PIK3C3, PIP4K2C, and PIP5K3. It requires Cys116 for JNK2 inhibition. [1] This chemical (10 mM) suppresses the IL-1β-stimulated phosphorylation of c-Jun in IL-1R cells, an established substrate of the JNKs. It covalently attaches to the JNK isoforms caused a small retardation in the electrophoretic mobility of the JNK isoforms. [2] It is discovered to inhibit JNK kinase by broad-based kinase selectivity profiling of a library of acrylamide kinase inhibitors based on the structure of using the KinomeScan approach. This compound possesses distinct regiochemistry of the 1,4-dianiline and 1,3-aminobenzoic acid substructures. It adopts an L-shaped type I binding conformation to access Cys 154 located toward the lip of the ATP-binding site. [3] |
| in vivo | JNK-IN-8 is a potent JNK inhibitor that specially targets JNK activation. It has anti-fungal activity. |
| 特徴 | JNK-IN-8 and JNK-IN-7 are structurally very similar, but whereas the former is a specific covalent inhibitor of JNKs. |
| キナーゼアッセイ | Binding Kinetics Assay | |
|---|---|---|
| Binding kinetics assay A375 cells are pretreated with 1 μM JNK-IN-8 for the indicated amounts of time. Remove the medium and wash three times with PBS. Resuspend the cell pellet with 1 mL Lysis Buffer (1% NP-40, 1% CHAPS, 25 mM Tris, 150 mM NaCl, Phosphatase Inhibitor Cocktail, and Protease Inhibitor Cocktail). Rotate end to end for 30 min at 4℃. Lysates are cleared by centrifugation at 1.4×104 rpm for 15 min in the Eppendorf. The cleared lysates are gel filtered into Kinase Buffer (0.1% NP-40, 20 mM HEPES, 150 mM NaCl, Phosphatase Inhibitor Cocktail, Protease Inhibitor Cocktail) using 10DG columns. The total protein concentration of the gel-filtered lysate should be around 5–15 mg/ml. Cell lysate is labeled with the probe from ActivX at 5 μM for 1 hour. Samples are reduced with DTT, and cysteines are blocked with iodoacetamide and gel filtered to remove excess reagents and exchange the buffer. Add 1 vol of 2× Binding Buffer (2% Triton-100, 1% NP-40, 2 mM EDTA, 2× PBS) and 50 μL streptavidin bead slurry, and rotate end to end for 2 hours, centrifuge at 7,000 rpm for 2 min. Wash three times with 1× Binding Buffer and three times with PBS. Add 30 μL 1× sample buffer to beads; heat samples at 95℃ for 10 min. Run samples on an SDS-PAGE gel at 110V. After transferred, the membrane is immunoblotted with JNK antibody. | ||
| 細胞アッセイ | 細胞株 | A375 cells |
| 濃度 | 4.7, 18.7 & 1 nM (JNK1, 2, & 3, respectively) | |
| 反応時間 | ||
| 実験の流れ | Cells were treated with various concentrations of JNK-IN-8. |
|
| 動物実験 | 動物モデル | C57BL/6 mice |
| 投薬量 | 10 mg/kg | |
| 投与方法 | i.p. | |
|

Data from [Biochem Biophys Res Commun, 2013, 440(4), 701-6]

Data from [Data independently produced by , , J Exp Med, 2015, 212(5): 775-92]

Data from [Data independently produced by , , Neurobiol Dis, 2018, 110:37-46]
| Macropinocytosis maintains CAF subtype identity under metabolic stress in pancreatic cancer [ Cancer Cell, 2025, S1535-6108(25)00271-5] | PubMed: 40712568 |
| Oncogenic RAS induces a distinctive form of non-canonical autophagy mediated by the P38-ULK1-PI4KB axis [ Cell Res, 2025, 10.1038/s41422-025-01085-9] | PubMed: 40055523 |
| SLFN11-mediated ribosome biogenesis impairment induces TP53-independent apoptosis [ Mol Cell, 2025, S1097-2765(25)00042-5] | PubMed: 39909041 |
| L1CAM signaling through planar cell polarity generates SOX2 + metastatic progenitors in lung adenocarcinoma [ bioRxiv, 2025, 2025.08.22.671773] | PubMed: 40894609 |
| [C6TSEDRVAJZ, a combination of small-molecule compounds, induces differentiation of human placental fibroblasts into epithelioid cells in vitro] [ Nan Fang Yi Ke Da Xue Xue Bao, 2025, 45(2):322-330] | PubMed: 40031976 |
| The ribotoxic stress response drives UV-mediated cell death [ Cell, 2024, 187(14):3652-3670.e40] | PubMed: 38843833 |
| Pharmacogenomic profiling of intra-tumor heterogeneity using a large organoid biobank of liver cancer [ Cancer Cell, 2024, 42(4):535-551.e8] | PubMed: 38593780 |
| Reversible covalent c-Jun N-terminal kinase inhibitors targeting a specific cysteine by precision-guided Michael-acceptor warheads [ Nat Commun, 2024, 15(1):8606] | PubMed: 39366946 |
| Jnk1 and downstream signalling hubs regulate anxiety-like behaviours in a zebrafish larvae phenotypic screen [ Sci Rep, 2024, 14(1):11174] | PubMed: 38750129 |
| Inhibition of JNK ameliorates rod photoreceptor degeneration in a mouse model of retinitis pigmentosa [ FEBS Lett, 2024, 10.1002/1873-3468.14978] | PubMed: 39010325 |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。